Defining regorafenib as a senomorphic drug: therapeutic potential in the age-related lung disease emphysema

Senescence, a hallmark of aging, is a factor in age-related diseases (ARDs). Therefore, targeting senescence is widely regarded as a practicable method for modulating the effects of aging and ARDs. Here, we report the identification of regorafenib, an inhibitor of multiple receptor tyrosine kinases,...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jung-Jin, Oh, Kwangseok, Lee, Gun-Wu, Bang, Geul, Park, Jin-Hee, Kim, Han-Byeol, Kim, Jin Young, Shin, Eun-Young, Kim, Eung-Gook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167251/
https://www.ncbi.nlm.nih.gov/pubmed/37009796
http://dx.doi.org/10.1038/s12276-023-00966-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167251/
https://www.ncbi.nlm.nih.gov/pubmed/37009796
http://dx.doi.org/10.1038/s12276-023-00966-6

Ejemplares similares